You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-C-MYC (MYC) Antibodies

Full name:
anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) Antibodies (MYC)
On www.antibodies-online.com are 695 V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies from 33 different suppliers available. Additionally we are shipping C-MYC Kits (47) and C-MYC Proteins (27) and many more products for this protein. A total of 798 C-MYC products are currently listed.
Synonyms:
AU016757, bHLHe39, C-MYC, CMyc, LOC100136746, mMyc, MRTL, MYC, Myc2, MYCC, Niard, Nird, RNCMYC, zc-myc
list all antibodies Gene Name GeneID UniProt
Anti-Rat MYC MYC 24577 P09416
MYC 17869 P01108
MYC 4609 P01106

Show all species

Show all synonyms

All available anti-C-MYC Antibodies

Go to our pre-filtered search.

Top referenced anti-C-MYC Antibodies

  1. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN358293 : Qi, Gregory, Li, Brousal, West, Hann: p19ARF directly and differentially controls the functions of c-Myc independently of p53. in Nature 2004 (PubMed)
    Show all 5 references for ABIN358293

  2. Human Monoclonal C-MYC Primary Antibody for IF, IHC (p) - ABIN1105578 : Liao, Thakur, Wu, Biliran, Sarkar: Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. in Critical reviews in oncogenesis 2008 (PubMed)
    Show all 4 references for ABIN1105578

  3. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN4620435 : Lima, Bousquet, Gomez-Brouchet, de Paiva, Amstalden, Soares, Dastugue, Vassallo, Brousset: Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene. in American journal of clinical pathology 2008 (PubMed)
    Show all 3 references for ABIN4620435

  4. Human Polyclonal C-MYC Primary Antibody for EIA, IHC (p) - ABIN4620434 : Ida, Ogata, Okumura, Taguchi: Changes in the gene expression of C-myc and CD38 in HL-60 cells during differentiation induced by nicotinic acid-related compounds. in Bioscience, biotechnology, and biochemistry 2008 (PubMed)
    Show all 3 references for ABIN4620434

  5. Human Polyclonal C-MYC Primary Antibody for EIA, WB - ABIN4620436 : Iijima, Teraoka, Date, Tsukada: DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. in European journal of biochemistry / FEBS 1992 (PubMed)
    Show all 3 references for ABIN4620436

  6. Human Monoclonal C-MYC Primary Antibody for EIA, FACS - ABIN119684 : Spandidos, Pintzas, Kakkanas, Yiagnisis, Mahera, Patra, Agnantis: Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue. in Anticancer research 1988 (PubMed)
    Show all 2 references for ABIN119684

  7. Human Monoclonal C-MYC Primary Antibody for FACS, IHC (fro) - ABIN119682 : Evan, Lewis, Ramsay, Bishop: Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. in Molecular and cellular biology 1986 (PubMed)
    Show all 2 references for ABIN119682

  8. Human Polyclonal C-MYC Primary Antibody for WB - ABIN2668789 : Kohn, Yang, Du, Nagano, Van Schyndle, Herrmann, Heldman, Chen, Stuelten, Flanders, Wakefield: Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. in Molecular cancer research : MCR 2012 (PubMed)

  9. Mammalian Monoclonal C-MYC Primary Antibody for IF, IP - ABIN1105582 : Watanabe, Honma, Furusawa, Sakurai, Sato: Preparation of enzymatically active human Myc-tagged-NCre recombinase exhibiting immunoreactivity with anti-Myc antibody. in Molecular reproduction and development 2006 (PubMed)

More Antibodies against C-MYC Interaction Partners

Mouse (Murine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. These results suggested that Notch2 (show NOTCH2 Antibodies) signaling is linked to c-Myc expression and plays a key role in the regulation of MSC (show MSC Antibodies) proliferation.

  2. this study demonstrates that the proto-oncoprotein Myc is a cell-intrinsic division timer, which regulates the extent of lymphocyte proliferative response

  3. Data show that expression of the Oct-4 (show POU5F1 Antibodies), Sox2 (show SOX2 Antibodies), Klf4 (show KLF4 Antibodies), and c-Myc (OSKM) reprogramming factors induces Cyclin D1 (show CCND1 Antibodies) expression, and the increased Cyclin D1 (show CCND1 Antibodies) expression during reprogramming promotes continuing embryonic fibroblasts (MEFs) proliferation.

  4. demonstrate a critical link between Myc/Mycn (show MYCN Antibodies) gene activity and glycolysis in spermatogonial stem cell self-renewal

  5. c-Myc gene expression in tumor tissues of mice treated I.V or IT with MSCs was down-regulated to 28.0% and 16.0% respectively compare to control groups. In conclusion, growth inhibition of breast tumors in mice due to MSC (show MSC Antibodies) therapy is associated with modulation of c-Myc activation and angiogenesis markers.

  6. BRG1 (show SMARCA4 Antibodies)/BRM (show SMARCA2 Antibodies) and c-MYC have an antagonistic relationship regulating the expression of cardiac conduction genes that maintain contractility, which is reminiscent of their antagonistic roles as a tumor suppressor and oncogene (show RAB1A Antibodies) in cancer.

  7. results indicate that the role of Myc in Hepatoblastoma pathogenesis is to impose mutually dependent changes in gene expression and metabolic reprogramming that are unattainable in non-transformed cells and that cooperate to maximize tumor growth

  8. The long intergenic non-coding RNA CCR492 functions as a let-7 competitive endogenous RNA to de-repress c-Myc expression and to promote cell transformation assisted by the constitutively active H-Ras (show HRAS Antibodies).

  9. this study shows that siRNA-mediated depletion of Myc reduced the expression of IL-4 (show IL4 Antibodies)-inducible genes in macrophages

  10. Findings identify BCL2A/A1 as a MYC target that can be induced prematurely during B cell development to aid expansion of otherwise cell-death-prone MYC transgenic pre-B cells.

Zebrafish V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Apoptosis was also observed with myca expression; introduction of homozygous tp53 (show TP53 Antibodies)(-/-) mutation into the myca transgenic fish reduced apoptosis and accelerated tumor progression.

  2. MYC down-regulation induces mitochondrial apoptosis in T lymphoblasts.

Human V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. BRD4 (show BRD4 Antibodies) positively regulates EZH2 (show EZH2 Antibodies) transcription through upregulation of C-MYC, and is a novel promising target for pharmacologic treatment in transcriptional program intervention against this intractable disease.

  2. The mechanism of inhibition of c-Myc transcriptional activity by Miz-1 (show ZBTB17 Antibodies) that binds c-Myc while competing for binding with Max has been described.

  3. c-Myc co-ordinates mRNA cap methylation and ribosomal RNA production.

  4. Inhibition of mTORC1-mediated 4EBP1 (show EIF4EBP1 Antibodies) phosphorylation leads to decreased expression of c-MYC and subsequent upregulation of the proapoptotic BCL2 (show BCL2 Antibodies) family member PUMA (show BBC3 Antibodies), whereas inhibition of mTORC2 (show CRTC2 Antibodies) results in nuclear factor-kappaB-mediated expression of the Early Growth Response 1 (EGR1 (show EGR1 Antibodies)) gene, which encodes a transcription factor that binds and transactivates the proapoptotic BCL2L11 (show BCL2L11 Antibodies) locus encoding BIM (show BCL2L11 Antibodies).

  5. feedback regulation between cMyc and p53 (show TP53 Antibodies) is important for the T cell homeostasis.

  6. MYC and TEAD activity is able to stratify different breast cancer subtypes in large panels of breast cancer patients.

  7. Analysis of microarray data sets further demonstrated that MUC1 (show MUC1 Antibodies) levels positively correlate with MYC expression in multiple myeloma progression

  8. c-Myc overexpression may increase sensitivity to poly(I:C)-induced tumor growth arrest and ROS (show ROS1 Antibodies)-mediated apoptosis in neuroblastoma (show ARHGEF16 Antibodies). This study demonstrates that c-Myc protein expression has an important role in TLR3 (show TLR3 Antibodies)-induced innate immune responses.

  9. Prediction model based on the marker MYC determines progression risk in non-dysplastic Barrett's esophagus.

  10. INI1 (show SMARCB1 Antibodies) re-expression suppresses cell proliferation and MYC-potentiated transformation.

Rabbit V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. report the isolation of complete coding regions of rabbit SOX2, KLF4, C-MYC and NANOG, which encode transcription factors that play crucial regulatory roles during early mammalian embryonic development

Cow (Bovine) V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) interaction partners

  1. Ouabain-induced proliferation might be attributed, at least in part, to decrease of intracellular free calcium and increase of c-myc mRNA expression, and that may be directly or indirectly involved in regulation of blood pressure.

C-MYC (MYC) Antigen Profile

Antigen Summary

The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene.

Alternative names and synonyms associated with C-MYC (MYC)

  • v-myc myelocytomatosis viral oncogene homolog (LOC100136746) antibody
  • myelocytomatosis oncogene (Myc) antibody
  • myelocytomatosis oncogene a (myca) antibody
  • v-myc avian myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (MYC) antibody
  • v-myc myelocytomatosis viral oncogene homolog (avian) (MYC) antibody
  • AU016757 antibody
  • bHLHe39 antibody
  • C-MYC antibody
  • CMyc antibody
  • LOC100136746 antibody
  • mMyc antibody
  • MRTL antibody
  • MYC antibody
  • Myc2 antibody
  • MYCC antibody
  • Niard antibody
  • Nird antibody
  • RNCMYC antibody
  • zc-myc antibody

Protein level used designations for MYC

v-myc myelocytomatosis viral oncogene homolog , Avian myelocytomatosis viral (v-myc) oncogene homolog , myc proto-oncogene protein , myelocytomatosis viral oncogene homolog , proto-oncogene c-Myc , transcription factor p64 , v-myc avian myelocytomatosis viral oncogene homolog , c-myc proto-oncogene , C-Myc1 , c-Myc-A , cellular myelocytomatosis oncogene , cmyca , transcriptional regulator Myc-A , avian myelocytomatosis viral oncogene homolog , class E basic helix-loop-helix protein 39 , myc-related translation/localization regulatory factor , avian myelocytomatosis viral (v-myc) oncogene homolog , c-Myc , Proto-oncogene c-Myc , Transcription factor p64 , Myc proto-oncogene protein

GENE ID SPECIES
100136746 Oncorhynchus mykiss
24577 Rattus norvegicus
17869 Mus musculus
30686 Danio rerio
4609 Homo sapiens
420332 Gallus gallus
100327265 Oryctolagus cuniculus
403924 Canis lupus familiaris
448810 Sus scrofa
511077 Bos taurus
100379628 Felis catus
443447 Ovis aries
694626 Macaca mulatta
464393 Pan troglodytes
100407754 Callithrix jacchus
100972175 Pan paniscus
Selected quality suppliers for anti-C-MYC (MYC) Antibodies
Did you look for something else?